Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;52(1):101-106.
doi: 10.1007/s42770-020-00327-9. Epub 2020 Jul 2.

Anti-Sporothrix activity of ibuprofen combined with antifungal

Affiliations

Anti-Sporothrix activity of ibuprofen combined with antifungal

Luana Pereira Borba-Santos et al. Braz J Microbiol. 2021 Mar.

Abstract

The in vitro activity of ibuprofen, a nonsteroidal anti-inflammatory drug, was evaluated against Sporothrix brasiliensis and S. schenckii, either alone or in combination with amphotericin B, itraconazole, or terbinafine. The inhibitory activity of ibuprofen as a single agent was determined according to minimum inhibitory concentration (MIC) values, while the effect of ibuprofen combined with amphotericin B, itraconazole, or terbinafine was estimated by microdilution checkerboard methodology. The ultrastructural alterations of S. schenckii after exposure to the combination of ibuprofen and amphotericin B were evaluated by scanning electron microscopy (SEM) and flow cytometry analysis. As a single agent, ibuprofen inhibited Sporothrix growth with a MIC median of 256 μg/mL, while the MIC medians of ibuprofen in combination with antifungals were 16 μg/mL and 128 μg/mL. The MIC values of amphotericin B, itraconazole, and terbinafine were reduced when isolates were co-incubated with ibuprofen, mainly the polyene. The major alteration after treatment with the ibuprofen/amphotericin B combination was the increase in the presence of filamentous forms and high membrane damage with loss of plasma membrane integrity. In summary, we demonstrated that ibuprofen increases the in vitro activity of antifungals, mainly amphotericin B, against S. brasiliensis and S. schenckii. Future in vivo studies exploring combination therapy with ibuprofen and antifungals in animal models are needed to confirm its efficacy.

Keywords: Amphotericin B; Ibuprofen; Sporothrix brasiliensis; Sporothrix schenckii.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Sporothrix schenckii alterations after exposure to the combination of ibuprofen and amphotericin B evaluated by scanning electron microscopy. The untreated culture exhibits yeasts with elongated shape, budding yeasts, and hyphae (a), while cultures treated with 128 μg/mL ibuprofen (b) or 0.001 μg/mL amphotericin B (c) show conidia with altered structure and amorphous cells (arrows). A chlamydospore-like structure was observed after exposure to the ibuprofen/amphotericin B combination (arrow in d), and filamentous forms were the most frequent after this treatment (e). Bars: 10 μm

References

    1. Rodrigues AM, Terra PPD, Gremião ID, Pereira SA, Orofino-Costa R, de Camargo ZP (2020) The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia.:1–30. 10.1007/s11046-020-00425-0 - PubMed
    1. Rodrigues AM, de Hoog GS, de Camargo ZP. Sporothrix species causing outbreaks in animals and humans driven by animal-animal transmission. PLoS Pathog. 2016;12:e1005638. doi: 10.1371/journal.ppat.1005638. - DOI - PMC - PubMed
    1. Orofino-Costa R, Macedo PM, Rodrigues AM, Bernardes-Engemann AR. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017;92:606–620. doi: 10.1590/abd1806-4841.2017279. - DOI - PMC - PubMed
    1. Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Clinical practice guideline for the management of sporotrichosis: 2007 update by Infectious Disease Society of America. Clin Infect Dis. 2007;45:1255–1265. doi: 10.1086/522765. - DOI - PubMed
    1. Katragkou A, Roilides E, Walsh TJ. Can repurposing of existing drugs provide more effective therapies for invasive fungal infections? Expert Opin Pharmacother. 2016;17:1179–1182. doi: 10.1080/14656566.2016.1186647. - DOI - PubMed

MeSH terms